Xiaohong Song

Title: Innovations and Contributions of Inventor Xiaohong Song

Introduction

Xiaohong Song is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant adenoviruses for vaccine preparation. With a total of three patents to his name, his work has the potential to impact public health positively.

Latest Patents

One of Xiaohong Song's latest patents is a single plasmid vector system for packaging recombinant human adenovirus type 4. This innovative system includes an E3 region-deleted human adenovirus type 4 genome, a vector sequence for amplifying plasmids in bacteria, a pBR322 replication origin, a kanamycin resistance gene, and a replication control sequence. The invention also provides a method for packaging the recombinant human adenovirus type 4, which can be utilized in vaccine and drug preparation. This vector system is designed for the rapid and efficient preparation of a human adenovirus type 4 vector recombinant virus, which can stably express an exogenous gene. It holds promise for applications in diagnostic kits, vaccines, gene therapy kits, and tumor therapy drugs.

Another notable patent involves a recombinant human replication-deficient adenovirus that comprises a modified nucleic acid encoding the Marburg virus envelope glycoprotein. This invention relates to a nucleotide sequence capable of expressing the Marburg virus envelope glycoprotein and a preparation method for a human replication-deficient recombinant adenovirus. The vaccine developed from this invention uses an E1 and E3 deleted replication-deficient human type-5 adenovirus as a vector, demonstrating significant expression of the envelope glycoprotein in transfected cells.

Career Highlights

Xiaohong Song has worked with esteemed institutions such as the Academy of Military Medical Science and the Institute of Biotechnology, both affiliated with the PLA. His work in these organizations has allowed him to focus on innovative research and development in the field of biotechnology.

Collaborations

Xiaohong has collaborated with notable colleagues, including Wei Chen and Shipo Wu, who have contributed to his research endeavors.

Conclusion

Xiaohong Song's innovative work in the field of biotechnology, particularly in the development of recombinant adenoviruses, showcases his significant contributions to public health. His patents reflect a commitment to advancing medical science and improving vaccine development.